Byrjalsen I - Search Results

1

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C. Dam EB, et al. Among authors: byrjalsen i. Osteoarthritis Cartilage. 2009 Mar;17(3):384-9. doi: 10.1016/j.joca.2008.07.009. Epub 2008 Sep 3. Osteoarthritis Cartilage. 2009. PMID: 18768336

2

Role of gastrointestinal hormones in postprandial reduction of bone resorption.

Henriksen DB, Alexandersen P, Bjarnason NH, Vilsbøll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C. Henriksen DB, et al. Among authors: byrjalsen i. J Bone Miner Res. 2003 Dec;18(12):2180-9. doi: 10.1359/jbmr.2003.18.12.2180. J Bone Miner Res. 2003. PMID: 14672353

3

Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.

Henriksen DB, Alexandersen P, Byrjalsen I, Hartmann B, Bone HG, Christiansen C, Holst JJ. Henriksen DB, et al. Among authors: byrjalsen i. Bone. 2004 Jan;34(1):140-7. doi: 10.1016/j.bone.2003.09.009. Bone. 2004. PMID: 14751571 Clinical Trial.

4

An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.

Cloos PA, Lyubimova N, Solberg H, Qvist P, Christiansen C, Byrjalsen I, Christgau S. Cloos PA, et al. Among authors: byrjalsen i. Clin Lab. 2004;50(5-6):279-89. Clin Lab. 2004. PMID: 15209436

5

The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.

Leeming DJ, Koizumi M, Byrjalsen I, Li B, Qvist P, Tankó LB. Leeming DJ, et al. Among authors: byrjalsen i. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):32-8. doi: 10.1158/1055-9965.EPI-05-0492. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434583

6

Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion.

Leeming DJ, Delling G, Koizumi M, Henriksen K, Karsdal MA, Li B, Qvist P, Tankó LB, Byrjalsen I. Leeming DJ, et al. Among authors: byrjalsen i. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1392-5. doi: 10.1158/1055-9965.EPI-05-0909. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835341

7

Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen.

Olsen AK, Sondergaard BC, Byrjalsen I, Tanko LB, Christiansen C, Müller A, Hein GE, Karsdal MA, Qvist P. Olsen AK, et al. Among authors: byrjalsen i. Osteoarthritis Cartilage. 2007 Mar;15(3):335-42. doi: 10.1016/j.joca.2006.08.015. Epub 2006 Oct 11. Osteoarthritis Cartilage. 2007. PMID: 17045814

8

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.

Byrjalsen I, Leeming DJ, Qvist P, Christiansen C, Karsdal MA. Byrjalsen I, et al. Osteoporos Int. 2008 Mar;19(3):339-48. doi: 10.1007/s00198-007-0462-5. Epub 2007 Sep 11. Osteoporos Int. 2008. PMID: 17846859 Clinical Trial.

9

The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality.

Karsdal MA, Byrjalsen I, Leeming DJ, Delmas PD, Christiansen C. Karsdal MA, et al. Among authors: byrjalsen i. Osteoporos Int. 2008 Sep;19(9):1355-61. doi: 10.1007/s00198-008-0603-5. Epub 2008 Apr 3. Osteoporos Int. 2008. PMID: 18385918 Clinical Trial.

10

Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers.

Leeming DJ, Hegele A, Byrjalsen I, Hofmann R, Qvist P, Karsdal MA, Schrader AJ, Wagner R, Olbert P. Leeming DJ, et al. Among authors: byrjalsen i. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1269-76. doi: 10.1158/1055-9965.EPI-07-2697. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18483350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results